IMS HEALTH, INC.

Inactive Instrument

IMS Health, Inc. Stock

Stocks

US4499341083

Biotechnology & Medical Research

End-of-day quote NYSE Other stock markets
- ^USD	-

Press Releases: IMS Health, Inc.

10-02-22	IMS HEALTH USD : Standard & Poor's Announces Changes to U.S. Indices	PR
-1-11-29	Ims Health Inc. : IMS to Present at the Bear Stearns Healthcare Conference on September 11 at 7:10 a.m. and 2:30 p.m. ET	BU
-1-11-29	Ims Health Inc. : IMS to Present at the Thomas Weisel Partners Conference on September 6 at 3:15 p.m. EDT	BU
-1-11-29	Ims Health Inc. : IMS Health Names Kevin Knightly Senior VP, Business Line Management; Adel Al-Saleh Appointed President, Europe, Middle East and Africa	BU
-1-11-29	Ims Health Inc. : IMS Health Delivers 11 Percent Revenue and Operating Income Growth in Second Quarter	BU

More press releases

News in other languages: IMS Health, Inc.

16-08-25	'WiWo': GfK-Mehrheitseigner erwägen Verkauf
16-08-25	KORREKTUR/'WiWo': Mehrheitseigner des Marktforschers GfK prüft Optionen
16-08-25	'WiWo': Mehrheitseigner des Marktforschers GfK prüft Optionen
09-10-08	IMS HEALTH USD : IMS relève ses prévisions de ventes pharmaceutiques mondiales
-1-11-29	Ims Health Inc. : IMS Health prévoit une croissance de 5 à 6 pour cent du marché pharmaceutique mondial en 2007

Managers and Directors: IMS Health, Inc.

Manager	Title	Age	Since
Ari Bousbib CEO	Chief Executive Officer	64	2016-09-30
Jon Resnick PSD	President	53	2019-06-30
James Berkshire COO	Chief Operating Officer	53	2017-06-30

Director	Title	Age	Since
Ari Bousbib CHM	Chairman	64	2016-09-30

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	-0.68%	-0.68%	-1.63%	+12.86%	48B
	REVOLUTION MEDICINES, INC.	+6.03%	+5.22%	+420.33%	+519.87%	41.13B
	IQVIA HOLDINGS INC.	-2.21%	-6.07%	+24.87%	+5.20%	37.56B
	BEONE MEDICINES AG	+2.94%	-2.25%	+6.15%	+59.69%	35.91B
	CELLTRION, INC.	+1.98%	+4.74%	+12.19%	+41.37%	29.86B
	ASCENDIS PHARMA A/S	+0.47%	-3.87%	-	-	16.12B
	MEDPACE HOLDINGS, INC.	+0.31%	+0.72%	+32.99%	+122.25%	16.05B
	EUROFINS SCIENTIFIC SE	+1.59%	+0.44%	+3.43%	+16.80%	13.76B
	ICON PUBLIC LIMITED COMPANY	-0.98%	-12.98%	-4.82%	-38.09%	12.1B
	Average	+1.05%	-1.81%	+61.69%	+92.49%	27.83B
	Weighted average by Cap.	+1.28%	-0.93%	+82.12%	+116.50%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

The best tools reserved for subscribers to boost the performance of your investments!